Single Versus Multi-Dose Oral and Intravenous Tranexamic Acid Patients at High Risk for Blood Transfusion After Spine Surgery

Condition:   Open Posterior Thoracolumbar Spinal Fusion Procedure Interventions:   Drug: Tranexamic Acid Injectable Product (1000 mg intravenous bolus);   Drug: Vitamin C 250 MG Oral Tablet;   Drug: Tranexamic Acid 650Mg Tablet Sponsor:   Rush University Medical Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials